Risk of Neonatal Short-Term Adverse Outcomes Associated with Noninfectious Intrapartum Hyperthermia: A Nested Case-Control Retrospective Study

Abstract

Objective This study aimed to identify risk factors for adverse neonatal outcomes in neonates born to mothers with noninfectious intrapartum hyperthermia.

Study Design A retrospective study was conducted of 460 singleton deliveries diagnosed with noninfectious intrapartum hyperthermia. Logistic regression was used to estimate the association between ante- and intrapartum risk factors and neonatal outcomes.

Results The 460 singleton pregnant women were 19 to 43 years of age. They developed an intrapartum temperature of ≥37.5°C somewhere between 34^0/7 to 41^4/7 weeks' gestation; 437 (95%) were nulliparous. Meconium-stained amniotic fluid was associated with positive pressure ventilation or intubation ventilation (odds ratio [OR] = 5.940, 95% confidence interval [CI]: 2.038–17.318), birth depression (OR = 6.288, 95% CI: 2.273–17.399), and wet lung (OR = 2.747, 95% CI: 1.322–5.709). Induction of labor with artificial rupture of membranes (AROM; OR = 2.632, 95% CI: 1.325–5.228) was associated with neonatal infections. Maternal temperature ≥ 38°C was associated with neonate's artery blood gas pH < 7.3 (OR = 2.366, 95%CI: 1.067–5.246) and wet lung (OR = 2.909, 95% CI: 1.515–5.586). Maternal elevated C-reactive protein (CRP) was associated with neonatal infections (OR = 1.993, 95% CI: 1.260–3.154) and wet lung (OR = 2.600, 95% CI: 1.306–5.178).

Conclusion Meconium-stained amniotic fluid, induction of labor, maternal temperature ≥ 38°C, and elevated CRP during labor were risk factors for adverse neonatal outcomes.

Keywords

maternal hyperthermia - noninfectious - meconium-stained amniotic fluid - induction of labor - neonatal short-term outcomes

Publication History

Received: 28 January 2019

Accepted: 06 September 2019

Article published online:
18 November 2019

• References

• 1 Verani JR, McGee L, Schrag SJ. Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010. MMWR Recomm Rep 2010; 59 (RR-10): 1-36
• 2 Towers CV, Yates A, Zite N, Smith C, Chernicky L, Howard B. Incidence of fever in labor and risk of neonatal sepsis. Am J Obstet Gynecol 2017; 216 (06) 596.e1-596.e5
• 3 Maayan-Metzger A, Mazkereth R, Shani A, Kuint J. Risk factors for maternal intrapartum fever and short-term neonatal outcome. Fetal Pediatr Pathol 2006; 25 (03) 169-177
• 4 Dior UP, Kogan L, Eventov-Friedman S. et al. Very high intrapartum fever in term pregnancies and adverse obstetric and neonatal outcomes. Neonatology 2016; 109 (01) 62-68
• 5 Wassen MM, Winkens B, Dorssers EM, Marcus MA, Moonen RM, Roumen FJ. Neonatal sepsis is mediated by maternal fever in labour epidural analgesia. J Obstet Gynaecol 2014; 34 (08) 679-683
• 6 Dior UP, Kogan L, Calderon-Margalit R. et al. The association of maternal intrapartum subfebrile temperature and adverse obstetric and neonatal outcomes. Paediatr Perinat Epidemiol 2014; 28 (01) 39-47
• 7 Petrova A, Demissie K, Rhoads GG, Smulian JC, Marcella S, Ananth CV. Association of maternal fever during labor with neonatal and infant morbidity and mortality. Obstet Gynecol 2001; 98 (01) 20-27
• 8 Lieberman E, Lang J, Richardson DK, Frigoletto FD, Heffner LJ, Cohen A. Intrapartum maternal fever and neonatal outcome. Pediatrics 2000; 105 (1 Pt 1): 8-13
• 9 Greenwell EA, Wyshak G, Ringer SA, Johnson LC, Rivkin MJ, Lieberman E. Intrapartum temperature elevation, epidural use, and adverse outcome in term infants. Pediatrics 2012; 129 (02) e447-e454
• 10 Lieberman E, Eichenwald E, Mathur G, Richardson D, Heffner L, Cohen A. Intrapartum fever and unexplained seizures in term infants. Pediatrics 2000; 106 (05) 983-988
• 11 Impey LW, Greenwood CE, Black RS, Yeh PS, Sheil O, Doyle P. The relationship between intrapartum maternal fever and neonatal acidosis as risk factors for neonatal encephalopathy. Am J Obstet Gynecol 2008; 198 (01) 49.e1-49.e6
• 12 Allen VM, Yudin MH. INFECTIOUS DISEASES COMMITTEE. Management of group B streptococcal bacteriuria in pregnancy. J Obstet Gynaecol Can 2012; 34 (05) 482-486
• 13 Cagno CK, Pettit JM, Weiss BD. Prevention of perinatal group B streptococcal disease: updated CDC guideline. Am Fam Physician 2012; 86 (01) 59-65
• 14 Prusakowski MK, Chen AP. Pediatric sepsis. Emerg Med Clin North Am 2017; 35 (01) 123-138
• 15 Siriwachirachai T, Sangkomkamhang US, Lumbiganon P, Laopaiboon M. Antibiotics for meconium-stained amniotic fluid in labour for preventing maternal and neonatal infections. Cochrane Database Syst Rev 2010; (12) CD007772
• 16 Sheiner E, Hadar A, Shoham-Vardi I, Hallak M, Katz M, Mazor M. The effect of meconium on perinatal outcome: a prospective analysis. J Matern Fetal Neonatal Med 2002; 11 (01) 54-59
• 17 Ojha RK, Singh SK, Batra S, Sreenivas V, Puliyel JM. Lactate: creatinine ratio in babies with thin meconium staining of amniotic fluid. BMC Pediatr 2006; 6: 13
• 18 Shaikh EM, Mehmood S, Shaikh MA. Neonatal outcome in meconium stained amniotic fluid-one year experience. J Pak Med Assoc 2010; 60 (09) 711-714
• 19 Kumari R, Srichand P, Devrajani BR. et al. Foetal outcome in patients with meconium stained liquor. J Pak Med Assoc 2012; 62 (05) 474-476
• 20 Aguilar AM, Vain NE. The suctioning in the delivery room debate. Early Hum Dev 2011; 87 (Suppl. 01) S13-S15
• 21 Rodríguez Fernández V, Ramón Y Cajal CNL, Ortiz EM, Naveira EC. Intrapartum and perinatal results associated with different degrees of staining of meconium stained amniotic fluid. Eur J Obstet Gynecol Reprod Biol 2018; 224: 192-197
• 22 Bhide S, Shendurnikar N, Aiyer SBaxi SR. Neonatal outcome after meconium-stained amniotic fluid. J Obstet Gynaecol India 1993; 44: 933-935
• 23 Cahill AG, Duffy CR, Odibo AO, Roehl KA, Zhao Q, Macones GA. Number of cervical examinations and risk of intrapartum maternal fever. Obstet Gynecol 2012; 119 (06) 1096-1101
• 24 Alexander JM, McIntire DM, Leveno KJ. Chorioamnionitis and the prognosis for term infants. Obstet Gynecol 1999; 94 (02) 274-278
• 25 Lau J, Magee F, Qiu Z, Houbé J, Von Dadelszen P, Lee SK. Chorioamnionitis with a fetal inflammatory response is associated with higher neonatal mortality, morbidity, and resource use than chorioamnionitis displaying a maternal inflammatory response only. Am J Obstet Gynecol 2005; 193 (3 Pt 1): 708-713
• 26 Aziz N, Cheng YW, Caughey AB. Neonatal outcomes in the setting of preterm premature rupture of membranes complicated by chorioamnionitis. J Matern Fetal Neonatal Med 2009; 22 (09) 780-784
• 27 Ramsey PS, Lieman JM, Brumfield CG, Carlo W. Chorioamnionitis increases neonatal morbidity in pregnancies complicated by preterm premature rupture of membranes. Am J Obstet Gynecol 2005; 192 (04) 1162-1166
• 28 Evers AC, Nijhuis L, Koster MP, Bont LJ, Visser GH. Intrapartum fever at term: diagnostic markers to individualize the risk of fetal infection: a review. Obstet Gynecol Surv 2012; 67 (03) 187-200